Evangelia Sarandi

Dr. Evangelia Sarandi

Laboratory of Toxicology, Medical School, University of Crete, Greece,71003
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Denisa MarginaDenisa Margina
Denisa Margina
AUAnca Ungurianu
Anca Ungurianu
NPNicoleta Carmen Purdel
Nicoleta Carmen Purdel
Dimitris TsoukalasDimitris Tsoukalas
Dimitris Tsoukalas
Evangelia SarandiEvangelia Sarandi
Evangelia Sarandi
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
The lifestyle adopted by most people in Western societies has an important impact on the propensity to metabolic disorders (e.g., diabetes, cancer, cardiovascular disease, neurodegenerative diseases). This is often accompanied by chronic low-grade inflammation, driven by the activation of various molecular pathways such as STAT3 (signal transducer and activator of transcription 3), IKK (IκB kinase), MMP9 (matrix metallopeptidase 9), MAPK (mitogen-activated protein kinases), COX2 (cyclooxigenase 2), and NF-Kβ (nuclear factor kappa-light-chain-enhancer of activated B cells). Multiple intervention studies have demonstrated that lifestyle changes can lead to reduced inflammation and improved health. This can be linked to the concept of real-life risk simulation, since humans are continuously exposed to dietary factors in small doses and complex combinations (e.g., polyphenols, fibers, polyunsaturated fatty acids, etc.). Inflammation biomarkers improve in patients who consume a certain amount of fiber per day; some even losing weight. Fasting in combination with calorie restriction modulates molecular mechanisms such as m-TOR, FOXO, NRF2, AMPK, and sirtuins, ultimately leads to significantly reduced inflammatory marker levels, as well as improved metabolic markers. Moving toward healthier dietary habits at the individual level and in publicly-funded institutions, such as schools or hospitals, could help improving public health, reducing healthcare costs and improving community resilience to epidemics (such as COVID-19), which predominantly affects individuals with metabolic diseases.

23 August 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
Dimitris TsoukalasDimitris Tsoukalas
Dimitris Tsoukalas
PFPersefoni Fragkiadaki
Persefoni Fragkiadaki
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
AAAthanasios K. Alegakis
Athanasios K. Alegakis
Evangelia SarandiEvangelia Sarandi
Evangelia Sarandi
Daniela CalinaDaniela Calina
Daniela Calina
Telomere length, a marker of cellular aging, decreases with age and it has been associated with aging‑related diseases. Environmental factors, including diet and lifestyle factors, affect the rate of telomere shortening which can be reversed by telomerase. Telomerase activation by natural molecules has been suggested to be an anti‑aging modulator that can play a role in the treatment of aging‑related diseases. This study aimed to investigate the effect of natural compounds on telomerase activity in human peripheral blood mononuclear cells (PBMCs). The tested compounds included Centella asiatica extract formulation (08AGTLF), Astragalus extract formulation (Nutrient 4), TA‑65 (containing Astragalus membranaceus extract), oleanolic acid (OA), maslinic acid (MA), and 3 multi‑nutrient formulas (Nutrients 1, 2 and 3) at various concentrations. The mean absorbance values of telomerase activity measured following treatment with some of the above‑mentioned formulations were statistically significantly higher compared to those of the untreated cells. In particular, in order of importance with respect to telomerase activation from highest to lowest, 08AGTLF, OA, Nutrient 4, TA‑65, MA, Nutrient 3 and Nutrient 2, triggered statistically significant increase in telomerase activity compared to the untreated cells. 08AGTLF reached the highest levels of telomerase activity reported to date, at least to our knowledge, increasing telomerase activity by 8.8 folds compared to untreated cells, while Nutrient 4 and OA were also potent activators (4.3‑fold and 5.9‑fold increase, respectively). On the whole, this study indicates that the synergistic effect of nutrients and natural compounds can activate telomerase and produce more potent formulations. Human clinical studies using these formulations are required to evaluate their mode of action. This would reveal the health benefits of telomerase activation through natural molecules and would shed new light onto the treatment of aging‑related diseases.

25 June 2020 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
Mayya RazgonovaMayya Razgonova
Mayya Razgonova
AZAlexander M. Zakharenko
Alexander M. Zakharenko
KGKirill S. Golokhvast
Kirill S. Golokhvast
MTMaria Thanasoula
Maria Thanasoula
Evangelia SarandiEvangelia Sarandi
Evangelia Sarandi
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
The current review focuses on the connection of telomerase and telomeres with aging. In this review, we describe the changes in telomerase and telomere length (TEL) during development, their role in carcinogenesis processes, and the consequences of reduced telomerase activity. More specifically, the connection of TEL in peripheral blood cells with the development of aging‑associated diseases is discussed. The review provides systematic data on the role of telomerase in mitochondria, the biology of telomeres in stem cells, as well as the consequences of the forced expression of telomerase (telomerization) in human cells. Additionally, it presents the effects of chronic stress exposure on telomerase activity, the effect of TEL on fertility, and the effect of nutraceutical supplements on TEL. Finally, a comparative review of the chronographic theory of aging, presented by Olovnikov is provided based on currently available scientific research on telomere, telomerase activity, and the nature of aging by multicellular organisms.

1 November 2019 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
Dimitris TsoukalasDimitris Tsoukalas
Dimitris Tsoukalas
VFVassileios Fragoulakis
Vassileios Fragoulakis
Evangelia SarandiEvangelia Sarandi
Evangelia Sarandi
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
EPEvangelos Papakonstaninou
Evangelos Papakonstaninou
Daniela CalinaDaniela Calina
Daniela Calina
Autoimmune diseases (ADs) are rapidly increasing worldwide and accumulating data support a key role of disrupted metabolism in ADs. This study aimed to identify an improved combination of Total Fatty Acids (TFAs) biomarkers as a predictive factor for the presence of autoimmune diseases. A retrospective nested case-control study was conducted in 403 individuals. In the case group, 240 patients diagnosed with rheumatoid arthritis, thyroid disease, multiple sclerosis, vitiligo, psoriasis, inflammatory bowel disease and other AD were included and compared to 163 healthy individuals. Targeted metabolomic analysis of serum TFAs was performed using GC-MS, and 28 variables were used as input for the predictive models. The primary analysis identified 12 variables that were statistically significantly different between the two groups, and metabolite-metabolite correlation analysis revealed 653 significant correlation coefficients with 90% level of significance (p<0.05). Three predictive models were developed, namely a) a logistic regression based on Principal Component Analysis (PCA), b) a straightforward logistic regression model and c) an Artificial Neural Network (ANN) model. PCA and straightforward logistic regression analysis, indicated reasonably well adequacy (74.7% and 78.9% respectively). For the ANN, a model using two hidden layers and 11 variables was developed, resulting in 76.2% total predictive accuracy. The models identified important biomarkers: lauric acid (C12:0), myristic acid (C14:0), stearic acid (C18:0), lignoceric acid (C24:0), palmitic acid (C16:0) and heptadecanoic acid (C17:0) among saturated fatty acids, Cis-10-pentadecanoic acid (C15:1), Cis-11-eicosenoic acid (C20:1n9) and erucic acid (C22:1n9) among monounsaturated fatty acids and the Gamma-linolenic acid (C18:3n6) polyunsaturated fatty acid. The metabolic pathways of the candidate biomarkers are discussed in relation to ADs. The findings indicate that the metabolic profile of serum TFAs is associated with the presence of ADs and can be an adjunct tool for the early diagnosis of ADs.

1 September 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
Denisa MarginaDenisa Margina
Denisa Margina
AUAnca Ungurianu
Anca Ungurianu
CPCarmen Purdel
Carmen Purdel
GNGeorge Mihai Nițulescu
George Mihai Nițulescu
Dimitris TsoukalasDimitris Tsoukalas
Dimitris Tsoukalas
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis

19 June 2023 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
Evangelia SarandiEvangelia Sarandi
Evangelia Sarandi
SKSabine Krueger-Krasagakis
Sabine Krueger-Krasagakis
DTDimitris Tsoukalas
Dimitris Tsoukalas
PSPolytimi Sidiropoulou
Polytimi Sidiropoulou
GEGeorge Evangelou
George Evangelou
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
Psoriasis is a common inflammatory disease that affects mainly the skin. However, the moderate to severe forms have been associated with several comorbidities, such as psoriatic arthritis, Crohn’s disease, metabolic syndrome and cardiovascular disease. Keratinocytes and T helper cells are the dominant cell types involved in psoriasis development via a complex crosstalk between epithelial cells, peripheral immune cells and immune cells residing in the skin. Immunometabolism has emerged as a potent mechanism elucidating the aetiopathogenesis of psoriasis, offering novel specific targets to diagnose and treat psoriasis early. The present article discusses the metabolic reprogramming of activated T cells, tissue-resident memory T cells and keratinocytes in psoriatic skin, presenting associated metabolic biomarkers and therapeutic targets. In psoriatic phenotype, keratinocytes and activated T cells are glycolysis dependent and are characterized by disruptions in the TCA cycle, the amino acid metabolism and the fatty acid metabolism. Upregulation of the mammalian target of rapamycin (mTOR) results in hyperproliferation and cytokine secretion by immune cells and keratinocytes. Metabolic reprogramming through the inhibition of affected metabolic pathways and the dietary restoration of metabolic imbalances may thus present a potent therapeutic opportunity to achieve long-term management of psoriasis and improved quality of life with minimum adverse effects.